Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vcanbio Cell & Gene Engineering Corp., Ltd. (formerly Eastern Union Stem Cell & Gene Engineering) is a leading Chinese biotechnology company specializing in cell therapy and gene technology. The company operates one of China's largest networks of cord blood and stem cell banks, providing long-term storage services. Beyond storage, Vcanbio is actively involved in the development of regenerative medicine products, including mesenchymal stem cell therapies and CAR-T cell treatments for oncology. It also offers comprehensive genetic testing services for precision medicine. Headquartered in Tianjin, the company is listed on the Shanghai Stock Exchange and is a key player in the domestic life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eastern Union Stem Cell & Gene Engineering.